Sphingosine-1-phosphate derived from PRP-Exos promotes angiogenesis in diabetic wound healing via the S1PR1/AKT/FN1 signalling pathway

Abstract

Background: Sphingosine-1-phosphate (S1P), a key regulator of vascular homeostasis and angiogenesis, is enriched in exosomes derived from platelet-rich plasma (PRP-Exos). However, the potential role of PRP-Exos-S1P in diabetic wound healing remains unclear. In this study, we investigated the underlying mechanism of PRP-Exos-S1P in diabetic angiogenesis and wound repair. Methods: Exosomes were isolated from PRP by ultracentrifugation and analysed by transmission electron microscopy, nanoparticle tracking analysis and western blotting. The concentration of S1P derived from PRP-Exos was measured by enzyme-linked immunosorbent assay. The expression level of S1P receptor1–3 (S1PR1–3) in diabetic skin was analysed by Q-PCR. Bioinformatics analysis and proteomic sequencing were conducted to explore the possible signalling pathway mediated by PRP-Exos-S1P. A diabetic mouse model was used to evaluate the effect of PRP-Exos on wound healing. Immunofluorescence for cluster of differentiation 31 (CD31) was used to assess angiogenesis in a diabetic wound model. Results: In vitro, PRP-Exos significantly promoted cell proliferation, migration and tube formation. Furthermore, PRP-Exos accelerated the process of diabetic angiogenesis and wound closure in vivo. S1P derived from PRP-Exos was present at a high level, and S1PR1 expression was significantly elevated compared with S1PR2 and S1PR3 in the skin of diabetic patients and animals. However, cell migration and tube formation were not promoted by PRP-Exos-S1P in human umbilical vein endothelial cells treated with shS1PR1. In the diabetic mouse model, inhibition of S1PR1 expression at wounding sites decreased the formation of new blood vessels and delayed the process of wound closure. Bioinformatics analysis and proteomics indicated that fibronectin 1 (FN1) was closely related to S1PR1 due to its colocalization in the endothelial cells of human skin. Further study supported that FN1 plays an important role in the PRP-Exos-S1P-mediated S1PR1/protein kinase B signalling pathway. Conclusions: PRP-Exos-S1P promotes angiogenesis in diabetic wound healing via the S1PR1/protein kinase B/FN1 signalling pathway. Our findings provide a preliminary theoretical foundation for the treatment of diabetic foot ulcers using PRP-Exos in the future.

Keywords

Exosomes / Platelet-rich plasma / Diabetic foot ulcer / Wound healing / Sphingosine-1-phosphate

References

[1] Armstrong DG, Swerdlow MA, Armstrong AA, Conte MS, Padula WV, Bus SA. Five year mortality and direct costs of care for people with diabetic foot complications are comparable to cancer. J Foot Ankle Res. 2020; 13: 16.

[2] Everett E, Mathioudakis N. Update on management of diabetic foot ulcers. Ann N Y Acad Sci. 2018; 1411: 153-65.

[3] den Dekker A, Davis FM, Kunkel SL, Gallagher KA. Targeting epigenetic mechanisms in diabetic wound healing. Transl Res. 2019; 204: 39-50.

[4] Farahani M, Shafiee A. Wound healing: from passive to smart dressings. Adv Healthc Mater. 2021; 10: e2100477.

[5] Cucci LM, Satriano C, Marzo T, La Mendola D. Angiogenin and copper crossing in wound healing. Int J Mol Sci. 2021; 22: 19.

[6] Zhang Y, Li T, Zhao C, Li J, Huang R, Zhang Q. An integrated smart sensor dressing for real-time wound microenvironment monitoring and promoting angiogenesis and wound healing. Front Cell Dev Biol. 2021; 9: 701525.

[7] Veith AP, Henderson K, Spencer A, Sligar AD, Baker AB. Therapeutic strategies for enhancing angiogenesis in wound healing. Adv Drug Deliv Rev. 2019; 146: 97-125.

[8] Liang Y, Duan L, Lu J, Xia J. Engineering exosomes for targeted drug delivery. Theranostics. 2021; 11: 3183-95.

[9] He M, Guo X, Li T, Jiang X, Chen Y, Yuan Y. Comparison of allogeneic platelet-rich plasma with autologous platelet-rich plasma for the treatment of diabetic lower extremity ulcers. Cell Transplant. 2020; 29: 963689720931428.

[10] Xu P, Wu Y, Zhou L, Yang Z, Zhang X, Hu X. Platelet rich plasma accelerates skin wound healing by promoting re epithelialization. Burns Dent Traumatol. 2020; 8: tkaa028.

[11] Li T, Ma Y, Wang M, Wang T, Wei J, Ren R. Platelet-rich plasma plays an antibacterial, anti-inflammatory and cell proliferation-promoting role in an in vitro model for diabetic infected wounds. Infect Drug Resist. 2019; 12: 297-309.

[12] Akbarzadeh S, McKenzie MB, Rahman MM, Cleland H. Allogeneic platelet-rich plasma: is it safe and effective for wound repair? Eur Surg Res. 2021; 62: 1-9.

[13] Dad HA, Gu TW, Zhu AQ, Huang LQ, Peng LH. Plant exosome-like Nanovesicles: emerging therapeutics and drug delivery Nanoplatforms. Mol Ther. 2021; 29: 13-31.

[14] Spakova T, Janockova J, Rosocha J. Characterization and therapeutic use of extracellular vesicles derived from platelets. Int J Mol Sci. 2021; 22: 18.

[15] Tao SC, Guo SC, Zhang CQ. Platelet-derived extracellular vesicles: an emerging therapeutic approach. Int J Biol Sci. 2017; 13: 828-34.

[16] Rui S, Yuan Y, Du C, Song P, Chen Y, Wang H. Comparison and investigation of exosomes derived from platelet-rich plasma activated by different agonists. Cell Transplant. 2021; 30: 9636897211017833.

[17] McVey MJ, Weidenfeld S, Maishan M, Spring C, Kim M, Tabuchi A. Platelet extracellular vesicles mediate transfusion-related acute lung injury by imbalancing the sphingolipid rheostat. Blood. 2021; 137: 690-701.

[18] Tao SC, Yuan T, Rui BY, Zhu ZZ, Guo SC, Zhang CQ. Exosomes derived from human platelet-rich plasma prevent apoptosis induced by glucocorticoid-associated endoplasmic reticulum stress in rat osteonecrosis of the femoral head via the Akt/bad/Bcl-2 signal pathway. Theranostics. 2017; 7: 733-50.

[19] Guo SC, Tao SC, Yin WJ, Qi X, Yuan T, Zhang CQ. Exosomes derived from platelet-rich plasma promote the re-epithelization of chronic cutaneous wounds via activation of YAP in a diabetic rat model. Theranostics. 2017; 7: 81-96.

[20] Zhang Y, Wang X, Chen J, Qian D, Gao P, Qin T. Exosomes derived from platelet-rich plasma administration in site mediate cartilage protection in subtalar osteoarthritis. J Nanobiotechnology. 2022; 20: 56.

[21] Aoki M, Aoki H, Mukhopadhyay P, Tsuge T, Yamamoto H, Matsumoto NM. Sphingosine-1-phosphate facilitates skin wound healing by increasing angiogenesis and inflammatory cell recruitment with less scar formation. Int J Mol Sci. 2019; 20: 14.

[22] Cartier A, Leigh T, Liu CH, Hla T. Endothelial sphingosine 1-phosphate receptors promote vascular normalization and antitumor therapy. Proc Natl Acad Sci U S A. 2020; 117: 3157-66.

[23] Heller R, Chang Q, Ehrlich G, Hsieh SN, Schoenwaelder SM, Kuhlencordt PJ. Overlapping and distinct roles for PI3Kbeta and gamma isoforms in S1P-induced migration of human and mouse endothelial cells. Cardiovasc Res. 2008; 80: 96-105.

[24] Tawa H, Rikitake Y, Takahashi M, Amano H, Miyata M, Satomi-Kobayashi S. Role of afadin in vascular endothelial growth factor-and sphingosine 1-phosphate-induced angiogenesis. Circ Res. 2010; 106: 1731-42.

[25] Liu C, Li M, Dong ZX, Jiang D, Li X, Lin S. Heterogeneous microenvironmental stiffness regulates pro-metastatic functions of breast cancer cells. Acta Biomater. 2021; 131: 326-40.

[26] Saatci O, Kaymak A, Raza U, Ersan PG, Akbulut O, Banister CE. Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer. Nat Commun. 2020; 11: 2416.

[27] Theocharidis G, Thomas BE, Sarkar D, Mumme HL, Pilcher WJR, Dwivedi B. Single cell transcriptomic landscape of diabetic foot ulcers. Nat Commun. 2022; 13: 181.

[28] Yoshihara M, Kajiyama H, Yokoi A, Sugiyama M, Koya Y, Yamakita Y. Ovarian cancer-associated mesothelial cells induce acquired platinum-resistance in peritoneal metastasis via the FN1/Akt signaling pathway. Int J Cancer. 2020; 146: 2268-80.

[29] Liu X, Wu J, Zhu C, Liu J, Chen X, Zhuang T. Endothelial S1pr1 regulates pressure overload-induced cardiac remodelling through AKT-eNOS pathway. J Cell Mol Med. 2020; 24: 2013-26.

[30] Han YC, Tang SQ, Liu YT, Li AM, Zhan M, Yang M. AMPK agonist alleviate renal tubulointerstitial fibrosis via activating mitophagy in high fat and streptozotocin induced diabetic mice. Cell Death Dis. 2021; 12: 925.

[31] Okonkwo UA, Chen L, Ma D, Haywood VA, Barakat M, Urao N. Compromised angiogenesis and vascular integrity in impaired diabetic wound healing. PLoS One. 2020; 15: e0231962.

[32] Yu M, Liu W, Li J, Lu J, Lu H, Jia W. Exosomes derived from atorvastatin-pretreated MSC accelerate diabetic wound repair by enhancing angiogenesis via AKT/eNOS pathway. Stem Cell Res Ther. 2020; 11: 350.

[33] Fan X, Liu L, Shi Y, Guo F, He X, Zhao X. Recent advances of the function of sphingosine 1-phosphate (S1P) receptor S1P3. J Cell Physiol. 2021; 236: 1564-78.

[34] Duru EA, Fu Y, Davies MG. Role of S-1-P receptors and human vascular smooth muscle cell migration in diabetes and metabolic syndrome. J Surg Res. 2012; 177: e75-82.

[35] Kase Y, Uzawa K, Wagai S, Yoshimura S, Yamamoto JI, Toeda Y. Engineered exosomes delivering specific tumor-suppressive RNAi attenuate oral cancer progression. Sci Rep. 2021; 11: 5897.

[36] Han Q, Xie QR, Li F, Cheng Y, Wu T, Zhang Y. Targeted inhibition of SIRT6 via engineered exosomes impairs tumorigenesis and metastasis in prostate cancer. Theranostics. 2021; 11: 6526-41.

[37] Shi A, Li J, Qiu X, Sabbah M, Boroumand S, Huang TC. TGF-beta loaded exosome enhances ischemic wound healing in vitro and in vivo. Theranostics. 2021; 11: 6616-31.

[38] Iyer SR, Scheiber AL, Yarowsky P, Henn RF, 3rd, Otsuru S, Lovering RM. Exosomes isolated from platelet-rich plasma and mesenchymal stem cells promote recovery of function after muscle injury. Am J Sports Med. 2020; 48: 2277-86.